BAGNEUX, France--(BUSINESS WIRE)--Genomic Vision (GV:EN Paris), a French molecular diagnostics company specializing in the development of diagnostic tests for genetic diseases and cancers based on molecular combing technology, announced today that the Company management will be participating at Source Capital Group’s 2016 Disruptive Growth & Healthcare Conference taking place February 10-11, 2016 in New York City. Chief Executive Officer Aaron Bensimon, Ph.D., will present a corporate overview at 2:45PM Eastern time on February 10th.
